Bladderwrack whole thallus (Fucus vesiculosus)

Free to every reader. The safety section of every monograph is open to everyone, signed in or not. In an emergency call 000. For poisoning, call the Poisons Information Centre on 13 11 26.

15. Safety

Main safety point. Bladderwrack is an iodine source of unpredictable strength. At the Ph. Eur. range of 0.03 to 0.2 per cent iodine, every published practitioner dose above the HMPC dose can put a patient over the Australian adult upper level of 1,100 µg of iodine a day (section 12, Figure F10b), and iodine excess from kelp products has caused both hyperthyroidism and hypothyroidism in published cases. Anyone who develops palpitations, a fast heartbeat, tremor or other signs of an overactive thyroid, or new tiredness and other signs of an underactive one, while taking it should stop it and have thyroid function checked promptly [3,13]. People with thyroid disease or on thyroid medicines should not take it unless the iodine content of the product is known and thyroid function is monitored.

Adverse effects in trials. The randomised trials of bladderwrack material alone reported no serious adverse events [27,28,41]. Three of twelve participants on 5 g of dried thallus a day withdrew with gastrointestinal complaints [21]. No trial of bladderwrack material reported thyroid function, and every such trial excluded people with thyroid disease [21,27,33,41], so the trials say nothing about the population most at risk; the one kelp trial that measured it, reported by HMPC, found TSH rising [4]. HMPC lists undesirable effects as "none known" for the 260 mg dose [3].

Case reports (causality assessed with the WHO-UMC categories; Medicine review, 2026). Case reports are the lowest tier of evidence for frequency, and the product in most of them was "kelp" of unstated species; they show that the harm occurs and cannot show how often.

The species in most "kelp" products in these reports was not stated [5], so they are signals for brown-seaweed products, with bladderwrack among them.

Toxicology. In rats and mice given two F. vesiculosus extracts, the oral LD50 was 1,000 to more than 2,000 mg/kg; over 4 weeks at 200 and 750 mg/kg, white cell counts fell, amylase rose, sodium excretion rose without change in plasma sodium, and liver and kidney weight rose in males at the high dose with normal function (Zaragozá 2008, as reported by HMPC) [4]. No genotoxicity, carcinogenicity or reproductive toxicity studies exist, and for that reason HMPC could not enter the herb on its EU list [3,4]. In rabbits, dietary Ascophyllum at 5 to 10 per cent caused severe anaemia and death, and Fucus serratus a milder form; rats and pigs were unaffected [5].

Contraindications. The grade after each item says what kind of evidence stands behind it.

• Hypersensitivity to the active substance [3]. Regulatory standard wording.
• Hyperthyroidism and related cardiac problems [16]; Graves’ disease, Hashimoto’s thyroiditis, after partial thyroidectomy, and iodine excess, as HMPC reports from the literature [4]. Case reports of kelp-induced thyroid dysfunction and iodine physiology; no trial in these groups.
• Pregnancy and lactation (see below).
• Children: HMPC does not recommend use under 18 years [3]; Barnes considers use by children inadvisable [5]. Theoretical and regulatory; no paediatric data.

Warnings and precautions.

• Do not combine with other Fucus preparations, iodine-containing preparations or thyroid medicines [3].
• Monitor thyroid function in long use, for example every 4 months [4]; excess iodine can cause either over- or underactivity [5,13].
• Doses above the recommended can raise TSH; overdose may aggravate acne and cause palpitations, fast heart rate, tremor, blood-pressure changes and a raised metabolic rate [3].
• Hypertension, kidney disease and anaemia (fucoidan may reduce iron absorption) [4,5].
• Bulk-forming products should be taken with a full glass of water, and avoided with difficulty swallowing, because they swell [4].
• Choose lots with metal results against the Ph. Eur. limits (section 10).
• Stop 7 days before general anaesthesia [16].

Herb-drug interactions.

Pregnancy and lactation. HMPC does not recommend use in pregnancy or lactation for lack of data [3]; Mills and Bone list bladderwrack as contraindicated in both [13]; Barnes advises avoidance because of thyroid effects and possible contamination [5]; MediHerb advises caution in lactation and professional supervision in pregnancy [16]. The sources disagree in strength. Iodine needs rise in pregnancy (Australian RDI 220 µg) and lactation (270 µg), and the NHMRC upper level of 1,100 µg does not change [29]. Grade: no human data for the drug in pregnancy or lactation; every recommendation rests on iodine physiology and on the regulators and practice texts, so the evidence is theoretical. Medicine view (2026): because the iodine content of a lot is unpredictable and the fetal and infant thyroid is sensitive to excess iodine, bladderwrack should not be used in pregnancy or breastfeeding, and should not be used to meet the higher iodine needs of either; a measured iodine supplement is the better instrument.

Children and older people. Not recommended under 18 years [3]. For older people, HMPC gives the adult dose [3]; the Gherbon case was in a woman of 70 [49].

Overdose. Iodine toxicity: thyroid dysfunction, acne, palpitations [3]. Single doses of 2 to 3 g of iodine are probably lethal (SCF, as HMPC reports it) [4]; no bladderwrack dose approaches that.

Australian regulatory position. Iodine in a preparation for internal use at 300 µg or more per recommended daily dose is a Schedule 2 poison (pharmacy medicine) [8], and such a product must carry advisory statements that total iodine intake may exceed the recommended level and warning against use in pregnancy without professional advice [31]. A listed bladderwrack medicine must declare iodine as a mandatory component [6]. TGA website search, September 2026 and repeated October 2026 with the same counts: "fucus vesiculosus" returned 84 items, all ARTG entries or sponsor cancellations; "bladderwrack" returned 4 ARTG entries; "kelp iodine" returned 7 items, none a safety alert about kelp or bladderwrack. No TGA safety alert for bladderwrack or kelp was found.

Australian spontaneous reports (DAEN – medicines). The TGA Database of Adverse Event Notifications could not be queried in September 2026. It was searched in October 2026, with data to September 2026 [52]. Thirty-seven medicines in it list F. vesiculosus as an active ingredient, nearly all multi-ingredient products sold for weight, hair, energy or general nutrition. Together they carry 119 reports, 97 of them naming a single suspected medicine. The commonest terms were nausea (17 reports) and palpitations (13). One report had a fatal outcome; it was coded with nausea and malaise, and the public view of DAEN does not show which report it was.

Eighteen reports, for six products, carry a thyroid term (Figure F10m): hyperthyroidism (6), hypothyroidism (5), TSH increased (5), thyroxine increased (2), and one each of TSH decreased, thyroid disorder, thyroid mass and thyroiditis. Fourteen are for "Hair + Energy" tablets of Ascophyllum nodosum and F. vesiculosus with zinc; eleven of those were entered on 08/02/2022 and 09/02/2022 without an age, which suggests a single batch of reports (AIP reading). Two are for Cellasene (1999 and 2004). One is for FatBlaster Max, in a woman of 60 taking levothyroxine, coded with TSH decreased and thyroxine increased alongside drug-induced liver injury. One is for a kelp tablet containing F. vesiculosus alone, in a woman of 74 coded with TSH increased and hyperthyroidism (2019). A second report of a person taking levothyroxine, with hypothyroidism, concerns a Hair + Energy product. Inclusion in DAEN does not mean that an event was confirmed or caused by the medicine, no report records the product’s iodine content, and AIP has not assessed these reports for causality. Grade: spontaneous reports, a signal only. They point the same way as the published cases: products containing brown seaweeds, bladderwrack among them, appear in Australian reports of both thyroid overactivity and underactivity.

Referral. Anyone with thyroid disease, anyone taking thyroid medicines, lithium, other iodine-containing medicines or anticoagulants, and anyone pregnant, planning pregnancy or breastfeeding should consult a degree-qualified herbalist with competencies and adequate training in pharmacognosy before using bladderwrack.